نتائج البحث - "Hermann PC"

المصدر: Viszeralmedizin 2021 Gemeinsame Jahrestagung Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Sektion Endoskopie der DGVS, Deutsche Gesellschaft für Allgemein und Viszeralchirurgie (DGAV).

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e3a439f6f350fd49a7fabc98a248d325
https://doi.org/10.1055/s-0041-1733557

4

Functional genomic screening during somatic cell reprogramming identifies Dkk3 as a roadblock of organ regeneration

المؤلفون: F Arnold, Mahaddalkar PU, W Bergmann, J Gout, Kraus JM, E Roger, L Perkhofer, T Seufferlein, Hermann PC, A Kleger

المصدر: DGVS Digital: BEST OF DGVS.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4d1458f9871ed988fa4f489161e7ee8b
https://doi.org/10.1055/s-0040-1716151

5

A novel targeted treatment to eliminate cancer stem cells in human pancreatic cancer

المؤلفون: Huber, SL, Müller, TM, Hermann, PC, Herrler, T, Ellwart, JM, Bruns, CJ, Heeschen, C

المصدر: 125. Kongress der Deutschen Gesellschaft für Chirurgie; 20080422-20080425; Berlin; DOC08dgch9229 /20080416/

مصطلحات موضوعية: ddc: 610

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1175::01b21c3534ed5c82ad5f9ee909f34d54
http://www.egms.de/en/meetings/dgch2008/08dgch643.shtml

6

دورية أكاديمية

Emerging Roles of Small Extracellular Vesicles in Gastrointestinal Cancer Research and Therapy.

المؤلفون: Schneider N; Department for Internal Medicine 1, University Clinic Ulm, 89081 Ulm, Germany., Hermann PC; Department for Internal Medicine 1, University Clinic Ulm, 89081 Ulm, Germany., Eiseler T; Department for Internal Medicine 1, University Clinic Ulm, 89081 Ulm, Germany., Seufferlein T; Department for Internal Medicine 1, University Clinic Ulm, 89081 Ulm, Germany.

المصدر: Cancers [Cancers (Basel)] 2024 Jan 29; Vol. 16 (3). Date of Electronic Publication: 2024 Jan 29.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Find this article in full text from ProQuest

Full Text Finder

7

دورية أكاديمية

Targeting cancer stem cell OXPHOS with tailored ruthenium complexes as a new anti-cancer strategy.

المؤلفون: Alcalá S; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Villarino L; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Ruiz-Cañas L; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Couceiro JR; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Martínez-Calvo M; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Palencia-Campos A; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Navarro D; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Cabezas-Sainz P; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain., Rodriguez-Arabaolaza I; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Facultad de Ciencia y Técnología, Universidad del País Vasco, 48940, Leioa (Bizkaia), Spain., Cordero-Barreal A; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Trilla-Fuertes L; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain., Rubiolo JA; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain., Batres-Ramos S; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Vallespinos M; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., González-Páramos C; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Rodríguez J; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain., Gámez-Pozo A; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Biomedica Molecular Medicine SL, Madrid, Spain., Vara JÁF; Molecular Oncology and Pathology Lab, Instituto de Genética Médica y Molecular-INGEMM, Instituto de Investigación Hospital Universitario La Paz-IdiPAZ, Madrid, Spain.; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain., Fernández SF; Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, Spain., Berlinches AB; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Servicio de Anatomía Patológica, Hospital Universitario Ramón y Cajal, Madrid, Spain., Moreno-Mata N; Servicio de Cirugía Torácica, Hospital Universitario Ramón y Cajal, Madrid, Spain., Redondo AMT; Biobanco Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain., Carrato A; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain.; Pancreatic Cancer Europe (PCE) Chairperson, Brussels, Belgium., Hermann PC; Department of Internal Medicine I, Ulm University, Ulm, Germany., Sánchez L; Department of Zoology, Genetics and Physical Anthropology, Veterinary Faculty, USC, Lugo, Spain., Torrente S; Valuation, Transfer and Entrepreneurship Area, USC, Santiago de Compostela, Spain., Fernández-Moreno MÁ; Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Rare Diseases, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain., Mascareñas JL; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), and Departamento de Química Orgánica, Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain. joseluis.mascarenas@usc.es., Sainz B Jr; Department of Biochemistry, Autónoma University of Madrid, School of Medicine and Department of Cancer, Instituto de Investigaciones Biomédicas (IIBm) Sols-Morreale (CSIC-UAM), Madrid, Spain. bsainz@iib.uam.es.; Biomarkers and Personalized Approach to Cancer (BIOPAC) Group, Area 3 Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. bsainz@iib.uam.es.; Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain. bsainz@iib.uam.es.

المصدر: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Jan 27; Vol. 43 (1), pp. 33. Date of Electronic Publication: 2024 Jan 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Ruthenium*/pharmacology , Pancreatic Neoplasms*/drug therapy , Pancreatic Neoplasms*/metabolism, Humans ; Oxidative Phosphorylation ; Mitochondria/metabolism ; Neoplastic Stem Cells/metabolism

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

8

دورية أكاديمية

Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma.

المؤلفون: Alonso-Nocelo M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ruiz-Cañas L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sancho P; Translational Research Unit, Hospital Miguel Servet, Instituto de Investigacion Sanitaria Aragon, Zaragoza, Spain., Görgülü K; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Alcalá S; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Pedrero C; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Vallespinos M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., López-Gil JC; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Ochando M; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., García-García E; Departamento de Anatomía Patológica, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., David Trabulo SM; Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Martinelli P; Institute for Cancer Research, Comprehensive Cancer Center, Medizinische Universitat Wien, Wien, Austria., Sánchez-Tomero P; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Sánchez-Palomo C; Departamento de Anatomía, Histologia y Neurociencia, Universidad Autónoma de Madrid, Madrid, Spain., Gonzalez-Santamaría P; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain., Yuste L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain., Wörmann SM; Ahmed Cancer Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kabacaoğlu D; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Earl J; Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Martin A; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain., Salvador F; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain., Valle S; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Martin-Hijano L; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Carrato A; Molecular Epidemiology and Predictive Tumor Markers Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain, Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.; Alcala University, Madrid, Spain., Erkan M; University Research Center for Translational Medicine - KUTTAM, Istanbul, Turkey., García-Bermejo L; Biomarkers and Therapeutic Targets Group, Area 4, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Hermann PC; Department of Internal Medicine I, Ulm University, Ulm, Germany., Algül H; Comprehensive Cancer Center München, Klinikum rechts der Isar der Technischen Universität München, München, Germany., Moreno-Bueno G; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.; Fundación MD Anderson Internacional, Madrid, Spain., Heeschen C; Stem Cells and Cancer Group, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Center for Single-Cell Omics and Key Laboratory of Oncogenes and Related Genes, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Portillo F; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Cano A; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain.; Cancer and Human Molecular Genetics, Instituto de Investigación Sanitaria IdiPAZ, Madrid, Spain.; Breast Cancer Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain., Sainz B , Jr; Departament of Biochemistry, Universidad Autónoma de Madrid (UAM), Departament of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM, Madrid, Spain bsainz@iib.uam.es.; Cancer Stem Cells and Fibroinflammatory Microenvironment Group, Chronic Diseases and Cancer, Area 3, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.; Gastrointestinal Tumours Research Programme, Biomedical Research Network in Cancer (CIBERONC), Madrid, Spain.

المصدر: Gut [Gut] 2023 Feb; Vol. 72 (2), pp. 345-359. Date of Electronic Publication: 2022 Apr 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms*/pathology , Carcinoma, Pancreatic Ductal*/pathology, Humans ; Mice ; Animals ; Epithelial-Mesenchymal Transition/genetics ; Disease Models, Animal ; Macrophages/metabolism ; Amino Acid Oxidoreductases/genetics ; Pancreatic Neoplasms

Find this article in full text from ProQuest

Full Text Finder

9

دورية أكاديمية

Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC Mice.

المؤلفون: Tsesmelis M; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany., Tiwary K; Department of Internal Medicine I, University of Ulm, 89081 Ulm, Germany., Steiger K; Department of Pathology, School of Medicine, Technical University of Munich, 81675 Munich, Germany., Sperb N; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany., Gerstenlauer M; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany., Manfras U; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany., Maier HJ; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.; Novartis Pharma AG, 4056 Basel, Switzerland., Hermann PC; Department of Internal Medicine I, University of Ulm, 89081 Ulm, Germany., Chan LK; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.; Institute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.; Department of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland., Wirth T; Institute of Physiological Chemistry, University of Ulm, 89081 Ulm, Germany.

المصدر: Cancers [Cancers (Basel)] 2021 Sep 10; Vol. 13 (18). Date of Electronic Publication: 2021 Sep 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Find this article in full text from ProQuest

Full Text Finder

10

دورية أكاديمية

Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells.

المؤلفون: Walter K; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Rodriguez-Aznar E; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Ferreira MSV; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital of the RWTH Aachen, 52062 Aachen, Germany., Frappart PO; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany.; Institute of Toxicology, University Medical Centre of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany., Dittrich T; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Tiwary K; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Meessen S; Department of Urology, Ulm University, 89081 Ulm, Germany., Lerma L; Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain., Daiss N; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Schulte LA; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Najafova Z; Department of Surgery, University Medical Center Göttingen, 37075 Göttingen, Germany., Arnold F; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Usachov V; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Azoitei N; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Erkan M; Department of Surgery, Koç University School of Medicine, Istanbul 34450, Turkey.; Research Center for Translational Medicine, Koç University, Istanbul 34450, Turkey., Lechel A; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Brümmendorf TH; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital of the RWTH Aachen, 52062 Aachen, Germany., Seufferlein T; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Kleger A; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany., Tabarés E; Department of Preventive Medicine, Public Health and Microbiology, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain., Günes C; Department of Urology, Ulm University, 89081 Ulm, Germany., Johnsen SA; Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Gastroenterology Research, Mayo Clinic, Rochester, MN 55905, USA., Beier F; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, University Hospital of the RWTH Aachen, 52062 Aachen, Germany., Sainz B Jr; Department of Biochemistry, Universidad Autónoma de Madrid (UAM), 28049 Madrid, Spain.; Department of Cancer Biology, Instituto de Investigaciones Biomédicas 'Alberto Sols' (IIBM), CSIC-UAM, 28049 Madrid, Spain.; Chronic Diseases and Cancer, Area 3-Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 28049 Madrid, Spain., Hermann PC; Department of Internal Medicine I, University Medical Centre Ulm, 89081 Ulm, Germany.

المصدر: Cancers [Cancers (Basel)] 2021 Jun 23; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Find this article in full text from ProQuest

Full Text Finder

تنقيح النتائج